Pearson Nurse's Drug Guide 2022, 1st edition
Published by Pearson (June 8, 2021) © 2022
- Kelly Shields
- Kami Fox
- Christina Liebrecht
For nursing courses covering drugs or drug administration.
A long-trusted reference guide for safe, effective drug administration
Pearson Nurse's Drug Guide 2022 helps clinicians administer drugs safely in any health care setting. Drugs are listed alphabetically by generic name and indexed by both generic and trade name, enabling quick, easy lookup. Students can get clinical information for hundreds of drugs, including adverse reactions, interactions, side effects and impact on lab results.
This 2022 Edition has updated and expanded content throughout, including 20 new monographs for drugs recently approved by the FDA.
Hallmark features of this title
Actionable clinical information for specific drugs
- Drug monographs help nurses adjust diagnoses and interventions per drug.
- Glossary of Key Terms, Clinical Conditions, and Associated Signs and Symptoms covers the therapeutic effects of specific drugs.
Preparation for drug administration
- Detailed administration guidance is given for IV prep and various procedures.
- Dosage information across the lifespan prepares nurses to safely administer drugs to nearly any patient.
Focus on drug classes and families
- A listing of drug classifications and associated drug prototypes is helpful to new pharmacology students.
- Appendix references include US Schedules of Controlled Substances, FDA Pregnancy Information, Prescription Combination Drugs, and Herbal and Dietary Supplement Table.
New and updated features of this title
- NEW: The new edition features 20 new monographs for drugs recently approved by the FDA: Barhemsys® (amisulpride), Xofluza™ (baloxavir marboxil), Beovu® (brolucizumab-dbll), Adakveo® (crizanlizumab-tmca), Pifeltro™ (doravirine), Vyepti™ (eptinezumab-jjmr), Xerava™ (eravacycline), Aimovig® (erenumab-aooe), Akynzeo® (fosnetupitant and palonosetron), Nourianz™ (istradefylline), Pizensy™ (lactitol), Ongentys® (opicapone), Motegrity™ (prucalopride), Aemcolo® (rifamycin), Skyrizi® (risankizumab-rzaa), Seysara™ (sarecycline), Sunosi® (solriamfetol), Ibsrela® (tenapanor), Rinvoq™ (upadacitinib), and Oxbryta™ (voxelotor).
About our authors
Kelly Shields is associate dean and an associate professor of pharmacy practice at Ohio Northern University’s Raabe College of Pharmacy. She holds a Doctor of Pharmacy from Butler University and completed a fellowship in natural product information and research at the University of Missouri-Kansas City. She has practiced pharmacy in retail, community and academic settings and has worked as a freelance medical writer.
Kami Fox is the director and chair of and an associate professor in the Department of Nursing at Ohio Northern University. She holds BS and MS degrees in nursing from Wright State University in Dayton, Ohio, and a DNP from the University of Toledo. She is a certified pediatric nurse practitioner in primary care.
Christina Liebrecht is an assistant professor of nursing at Ohio Northern University. She holds a BS in nursing and a doctorate in nursing practice from the University of Toledo, as well as an MS degree in nursing from Walden University. She has been in nursing education for nearly two decades with a focus on medical surgical nursing, fundamentals of nursing, and community health nursing, as well as the use of simulation to support student learning and safe practice. She continues to practice as a medical surgical nurse in the acute care setting.
Need help? Get in touch